CRD-BP Protects the Coding Region of βTrCP1 mRNA from miR-183-Mediated Degradation

• DOI: 10.1016/j.molcel.2009.06.007
• Publication Date: 2009-07-31T17:09:07Z
• Authors: Irina Elcheva; Srikanta Goswami; Felicite K. Noubissi; Vladimir S. Spieg...
• Keywords: Ribonuclease III; 0301 basic medicine; Binding Sites; Recombinant Fusion Proteins; Eukaryotic Initiation Factor-2; RNA-Binding Proteins; Cell Biology; beta-Transducin Repeat-Containing Proteins; DEAD-box RNA Helicases; MicroRNAs; Open Reading Frames; 03 medical and health sciences; Argonaute Proteins; Humans; RNA-Induced Silencing Complex; RNA, Messenger; Molecular Biology

miRNAs are largely known to base pair with the 3'UTR of target mRNAs, downregulating their stability and translation. mRNA of betaTrCP1 ubiquitin ligase is very unstable, but unlike the majority of mRNAs where 3'UTR determines the rate of mRNA turnover, betaTrCP1 mRNA contains cis-acting destabilizing elements within its coding region. Here we show that degradation of mRNA of betaTrCP1 is miRNA dependent and identify miR-183 as a microRNA that interacts with the coding region of betaTrCP1 mRNA. Argonaute2 interacts with the same region of betaTrCP1 mRNA in an miR-183-dependent manner. Inhibition of miR-183 function or disruption of the miR-183-binding site stabilizes betaTrCP1 mRNA and elevates betaTrCP1 levels, resulting in activation of the SCF(betaTrCP) E3 ubiquitin ligase. We previously showed that the RNA-binding protein CRD-BP binds to the coding region of betaTrCP1 mRNA and stabilizes it. Here we demonstrate that CRD-BP prevents degradation of betaTrCP1 mRNA by attenuating its miR-183-dependent interaction with Ago2.